Skyline Diagnostics

Skyline Diagnostics develops and commercializes diagnostic products and services with a high additive clinical value for patients with cancer. The Profilers are based on gene expression microarray technology (Affymetrix GeneChip®).

Skyline Diagnostics products provides the clinician in-depth insight in the clinically relevant subtypes of the diseases, prognosis of individual patients and response to treatment. This information facilitates the treatment decision making process.

Skyline Diagnostics has several Profilers in development and launched its first product, the AMLProfiler for patients with Acute Myeloid Leukemia diagnosis, in January 2010.

Three additional Profilers are in development for Multiple Myeloma (MM), Acute Lymphatic Leukemia (ALL) and Brain tumors. Key factors for success are unrivalled R&D, stringent compliance with regulatory trajectories and successful commercialization of these Profilers. The company has built strong collaborations with leading scientists and has strategic alliances with industrial partners for development, manufacturing and distribution.

Our company is offering position for Postdocs in R&D, mainly in Molecular Biology and Bioinformatics. Due to the continued expansion of Skyline's activities, we are always interested to get in touch with enthusiastic, highly skilled, and motivated individuals with an academic background in micro-array technology or in life-sciences in general. We look for professionals interested to work in this dynamic surrounding in close collaboration with academic departments, but at the same time meet the challenges of a rapid expanding company with commercial goals. And we are open to give researchers a chance to growth in a more commercial direction.

More information is available on www.skyline-diagnostics.com or by email This e-mail address is being protected from spambots. You need JavaScript enabled to view it .